Moderate Drug Interaction

Can You Take Codeine with Duloxetine?

A plain-English look at the moderate interaction between Codeine (Aspen Pharmacare Australia Pty Ltd) and Duloxetine (APO-Duloxetine) — what it means, why it happens, and what to talk to your doctor or pharmacist about.

Moderate severity AllMeds interaction database Updated April 2026

Combining Codeine (Aspen Pharmacare Australia Pty Ltd) with Duloxetine (APO-Duloxetine) is a moderate interaction requiring caution and monitoring. Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.

Not sure about your specific combination? Check it in the Drug Interaction Checker →

Key Takeaways

  • Interaction severity: Moderate
  • Risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.
  • Mechanism: Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
  • Codeine: S8 in Australia, moderate risk
  • Duloxetine: S4 in Australia, low risk
  • Claims action: Monitor and document. Request clinical justification if combination is ongoing.

Codeine vs Duloxetine at a Glance

Property Codeine Duloxetine
Brand names Aspen Pharmacare Australia Pty Ltd APO-Duloxetine, Duloxetine Sandoz 60, Tixol 60
Drug class opioid antidepressant
Risk level moderate low
TGA Schedule (AU) S8 S4

Why Is This Combination Dangerous?

Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.

Clinical risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.

Regulatory Guidance by Jurisdiction

Australia TGA / SIRA / WorkSafe

The TGA and Australian Medicines Handbook classify this as a moderate drug interaction requiring monitoring and clinical review.

United Kingdom NICE / MHRA / FPM

NICE guidelines advise against combining multiple serotonergic medications due to the risk of serotonin syndrome. For personal injury claims, antidepressant prescribing should be reviewed for injury relatedness and appropriateness.

United States FDA / CDC / State WC

The FDA has issued Drug Safety Communications about the risk of serotonin syndrome with concurrent use of serotonergic medications. Workers compensation nurse case managers should flag this combination for prescriber review.

What Claims Professionals Should Do

  1. Document the combination in the claim file with a note on interaction risk
  2. Request clinical justification from the prescriber at the next review
  3. Monitor for adverse effects including excessive sedation, falls, and cognitive impairment
  4. Assess injury relatedness of both medications to the compensable condition
  5. Review at next claim assessment and consider whether the combination is still clinically appropriate

Check this medication against your full medication list

Check all interactions for Codeine and Duloxetine across your claimant's full medication list.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Related Resources

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.